# DenQAI first broker-call question set

**Version:** 2026.07  
**Status:** Educational worksheet; no user data  

Use these questions before disclosing your maximum financing, signing a letter of intent, or treating access to a listing as buyer representation.

## Role and representation

1. Who is your client in this transaction?
2. What duties do you have to the seller, buyer, or both under the written engagement and applicable state law?
3. Are you acting as a broker, transaction adviser, M&A adviser, consultant, valuator, or in another role?
4. Who should I hire to provide independent buyer-side legal, tax, financial, clinical, technology, and operating review?

## Fees, referrals, and relationships

5. Who pays you, how is the payment calculated, and what event triggers it?
6. Could the fee change with price, buyer type, financing, contingent consideration, real estate, or another service?
7. Do you or an affiliate receive referral, sourcing, marketing, financing, vendor, or repeat-business value from another participant?
8. Which lenders, DSOs, private buyers, vendors, attorneys, CPAs, consultants, or contractors regularly receive your referrals?
9. Are any participants owners, affiliates, sponsors, preferred providers, or parties to formal referral or data-sharing arrangements?

## Opportunity and marketing process

10. What must be signed before I receive the location, asking price, financial summary, and confidential memorandum?
11. What is the asking price, valuation effective date, valuation standard, adjustment method, and expected transaction structure?
12. Which assets, A/R, cash, liabilities, working capital, real estate, and transaction costs are included or excluded?
13. When did marketing begin, which buyer classes received the opportunity, and were any classes excluded?
14. Has a previous process, letter of intent, financing attempt, or closing failed? What can be disclosed and documented?
15. Will every written offer be logged and presented to the seller on the same defined basis?

## Buyer-repeatable practice

16. Can the seller provide provider-level production and collections, procedure mix, schedules, patient cohorts, payer relationships, team records, equipment, lease, and transition dependencies?
17. Which results depend on the seller’s procedures, pace, hours, payer status, relationships, or unpaid management work?
18. What changed in providers, hours, staffing, marketing, write-offs, maintenance, capital spending, or procedure mix during the three years before sale?
19. Which add-backs restore costs that this buyer will actually have to pay?
20. What evidence would contradict the claimed active-patient count, cash flow, growth rate, or transferability?

## Data boundary

21. What buyer information do you collect, who may receive it, for which uses, and for how long?
22. Will the seller, vendors, lenders, DSOs, or other buyers receive my financing capacity, personal financial information, clinical profile, or negotiation position?
23. What written consent, privacy notice, referral authorization, access control, retention, deletion, and incident process applies?

## Stop before proceeding

Do not let a verbal answer clear a material safety check. Record the supporting document, source date, limitation, reviewer, and the fact that would reverse the decision.